HomeProductsBuilding BlocksFunctional GroupsAminesPalmitoylethanolamide
Chemical structure of CAS 544-31-0

Palmitoylethanolamide

In Stock•Starting at $17 for 5 g•Purity ≥ 95%
CAS No.544-31-0
MDL No.MFCD00020562
MFC18H37NO2
MW299.50
InChI KeyHXYVTAGFYLMHSO-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 g95%$17In Stock
25 g95%$60In Stock
100 g95%$134In Stock
500 g95%$467In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Palmitoyl ethanolamide is an N-(long-chain-acyl)ethanolamine derived from palmitic acid (hexadecanoic acid). It functions as an anti-inflammatory, antihypertensive, neuroprotective, and anticonvulsant agent. It is an endocannabinoid and a N-(saturated fatty acyl)ethanolamine, with functional relationships to hexadecanoic acid.

CAS No.544-31-0
Product NamePalmitoylethanolamide

Associated Conditions

opioid use disorder·Mastocytosis·Chronic pain·Tourette syndrome·migraine disorder·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Endocannabinoids control spasticity in a multiple sclerosis model.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology • Vol. 15, Issue 2 • 2001
PMID: 11156943DOI: 10.1096/fj.00-0399fje

Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture.

Journal of neurochemistry • Vol. 76, Issue 2 • 2001
PMID: 11208922DOI: 10.1046/j.1471-4159.2001.00092.x

Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study.

Veterinary dermatology • Vol. 12, Issue 1 • 2001
PMID: 11301536DOI: 10.1046/j.1365-3164.2001.00214.x

Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.

British journal of pharmacology • Vol. 132, Issue 8 • 2001
PMID: 11309246PMC: PMC1572744DOI: 10.1038/sj.bjp.0704029

Documentation

Similar Products